Talphera Announces Fourth Quarter 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
Talphera, Inc. (TLPH)
Company Research
Source: Yahoo! Finance
First patient enrollment in the NEPHRO CRRT registrational study expected in Q1 2024 with a projected PMA submission by the end of 2024 Cash and investments at December 31, 2023 of $9.4 million together with the royalty and equity financings completed in January 2024 expected to provide cash runway to a potential Niyad™ approval in Q2 2025 Conference call and webcast to be held Wednesday, March 6, 2024 at 4:30 pm ET SAN MATEO, Calif. March 6, 2024 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced fourth quarter 2023 financial results and provided a corporate update. "We are excited about our company transformation to Talphera earlier this year. With the divestment of DSUVIA last year and priority focus on our new lead asset, Niyad, we expect a series of significant upcoming milestones. This transformat
Show less
Read more
Impact Snapshot
Event Time:
TLPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TLPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TLPH alerts
High impacting Talphera, Inc. news events
Weekly update
A roundup of the hottest topics
TLPH
News
- Talphera, Inc. (NASDAQ: TLPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.MarketBeat
- Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- Talphera Announces First Quarter 2024 Financial Results and Provides Corporate UpdatePR Newswire
- Talphera, Inc. (NASDAQ: TLPH) is now covered by analysts at Maxim Group. They set a "buy" rating and a $3.00 price target on the stock.MarketBeat
- Talphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024PR Newswire
TLPH
Earnings
- 5/14/24 - Beat
TLPH
Sec Filings
- 5/14/24 - Form 10-Q
- 5/14/24 - Form 8-K
- 4/29/24 - Form ARS
- TLPH's page on the SEC website